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Abstract
The chicken represents the best-characterized animal model for B cell development in the so-called
gut-associated lymphoid tissue (GALT) and the molecular processes leading to B cell receptor
diversification in this species are well investigated. However, the mechanisms regulating B cell
development and homeostasis in GALT species are largely unknown. Here we investigate the role
played by the avian homologue of B cell-activating factor of the tumor necrosis factor family (BAFF).
Flow cytometric analysis showed that the receptor for chicken B cell-activating factor of the tumor
necrosis factor family (chBAFF) is expressed by mature and immature B cells. Unlike murine and
human BAFF, chBAFF is primarily produced by B cells both in peripheral lymphoid organs and in the
bursa of Fabricius, the chicken’s unique primary lymphoid organ. In vitro and in vivo studies revealed
that chBAFF is required for mature B cell survival. In addition, in vivo neutralization with a decoy
receptor led to a reduction of the size and number of B cell follicles in the bursa, demonstrating that,
in contrast to humans and mice, in chickens BAFF is also required for the development of immature
B cells. Collectively, we show that chBAFF has phylogenetically conserved functions in mature B cell
homeostasis but displays unique and thus far unknown properties in the regulation of B cell
development in birds.
Introduction
B cell development in most domestic animals takes place in
gut-associated lymphoid tissues (GALTs). This was clearly
shown for rabbits (1, 2) and sheep (3), and more recently
for cattle (4, 5) and pigs (6). The most intensively studied
model organism for B cell development in the GALT is the
chicken (7) in which B cells differentiate in a unique organ,
the bursa of Fabricius. Studies performed mainly in chickens
indicate that the GALT pathway for B cell differentiation dif-
fers fundamentally in key aspects from the paradigm estab-
lished in humans and mice, but seems to be more of a rule
than an exception in domestic species.
In the human and mouse bone marrow, lymphopoesis
from progenitor cells to B cells is a livelong process
[reviewed in (8) and (9)]. In contrast, chicken B cell develop-
ment occurs in defined temporal steps known as pre-bursal,
bursal and post-bursal phases (10). During the pre-bursal
stage of development, hematopoietic precursor cells derived
from the intra-embryonic mesenchyme commit to the B cell
lineage and colonize the bursal anlage (11). Commitment to
the B cell lineage is manifested by Ig gene rearrangement
during a window of ;10 days in embryonic development
and initially takes place in the embryonic yolk sac. Subse-
quently, these committed cells spread to blood, spleen and
various lymphoid organs (12, 13). This small number of pre-
bursal stem cells migrates to the bursa, where only cells with
productive Ig gene rearrangement undergo proliferative ex-
pansion (14). Furthermore, B cell development in the bursal
environment triggers the diversification of the B cell receptor
(BCR) by gene conversion (15, 16). Beginning around hatch
and continuing until bursa involution, immature bursal B cells
with functional and diversified surface Igs start to emigrate
to the periphery and distribute to the secondary lymphoid
organs (17, 18). In striking contrast to humans and mice
where bone marrow B cell development is maintained for
the entire life, the bursa of Fabricius involutes with sexual ma-
turity. Thus, the peripheral B cell compartment in chickens is
maintained by a small pool of long-living, self-renewing
B cells, the so-called post-bursal stem cells (19).
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While the molecular events of BCR diversification in the
bursa are well understood, very little information exists on sig-
nals that control death, survival and developmental check-
points in the avian B cell compartment in general. Extensive
studies using retroviral gene transfer in vivo have shown that
the cytoplasmic domains of the Igab heterodimer are as effi-
cient as the endogenous complete BCR in supporting the
early stages of B cell differentiation (20, 21). However, for
further development and emigration from the bursa, an intact
surface IgMR complex is necessary. Of note, only a small
percentage of the newly generated cells emigrates while the
vast majority of bursal B cells dies by apoptosis (22–24).
In addition to B cell-intrinsic factors, signals derived from
the bursal microenvironment have been postulated to exist.
These include adhesion molecules which may support hom-
ing and emigration of B cells in and from the bursa (25) and
soluble factors. The soluble tripeptide bursin was described
as a factor which may act on the appearance of surface
IgM+ cells during bursa ontogeny (26, 27). Recently, we
were able to identify chicken B cell-activating factor of the
tumor necrosis factor family (chBAFF), the chicken homo-
logue of mammalian B cell-activating factor of the tumor necro-
sis factor family (BAFF/BLyS), as a potent B cell-specific
cytokine (28).
In mammals, members of the tumor necrosis factor (TNF)
family and their receptors are well known as important regu-
lators of B cell development and function (29, 30). BAFF is
a relatively new member of the TNF family of cytokines and
plays a major role in peripheral B cell survival and matura-
tion in humans and mice. Deregulated, increased BAFF produc-
tion is associated with autoimmune disorders like systemic
lupus erythematosus, rheumatoid arthritis and Sjo¨rgens syn-
drome (31–33). On the contrary, a lack of BAFF leads to
severe immunodeficiency as shown in BAFF-deficient mice
(34) and in cultured human cells (35). In mice, two distinct
sources of BAFF have been identified. Radiation-resistant
stroma cells constitutively express BAFF (36), and mono-
cytes, macrophages, dendritic cells (37, 38) and neutrophils
(39) produce BAFF in response to other cytokines. While the
constitutive BAFF pool controls the size of the peripheral
B cell pool (36, 40), the inducible fraction seems to be re-
quired for the accumulation of additional B cell populations,
for example, at sites of infection (41, 42). It was also shown
that neoplastic B cells can be a source of BAFF (43, 44) but
so far it is widely accepted that normal human and murine
B cells do not produce BAFF (44, 45).
BAFF can bind three receptors of the TNFR family, B cell
maturation antigen (BCMA); transmembrane activator, calcium
modulator and CAML interactor (TACI) and BAFFR. Interest-
ingly, BCMA and TACI can also bind a proliferation-inducing
ligand (APRIL), another member of the TNF family, while
BAFFR exclusively binds to BAFF. BAFFR is expressed
by all peripheral B cells (46, 47) and additionally by a small
T cell subset (35) where it is able to co-stimulate T cell acti-
vation (35). Interaction with BAFFR is essential for peripheral
B cell survival as well as the formation and differentiation of
marginal zone B cells (48). BCMA surface expression is re-
stricted to germinal centers and plasma cells and mediates
long-term survival of plasma cells (49). TACI is primarily
expressed on T2 and MZ B cells, and current functional data
suggest that TACI may serve as a negative regulator of B cell
activation. From intensive studies in mice and humans, the
generally accepted concept emerged that BAFF solely acts
on mature peripheral B cell, while early stages of human
and murine B cell development in the bone marrow are
BAFF independent (50). In the chicken genome, APRIL,
BCMA and TACI appear to be absent (51), leaving birds
with just BAFF and BAFFR homologues.
As previously reported, chBAFF also acts as survival fac-
tor for peripheral B cells in vitro and in vivo (28). Intriguingly,
in the chicken this cytokine is primarily expressed in the
bursa of Fabricius (28, 52) and expression of receptors for
chBAFF could be detected on all chicken B cells, including
immature bursal B cells. Here we extend our previous stud-
ies and demonstrate that BAFF has phylogenically con-
served functions on peripheral chicken B cells, and we
further demonstrate unique BAFF properties in this model
species with GALT-dependent B cell generation.
Methods
Animals
Fertilized eggs of the M11 (Bx2x/Bx2x) white leghorn chicken
line were obtained from the Institute for Animal Science
Mariensee (53) and hatched at the Institute of Animal
Physiology, Munich, Germany. Birds were housed under
conventional conditions in groups of up to 10 birds. All ani-
mal experiments were authorized by the Regierung von
Oberbayern (registration number 209.1/211-2531-46/03)
Cells
Chicken splenocytes, cells of the bursa of Fabricius and
the cecal tonsils were separated by density gradient centri-
fugation on Ficoll–Paque (Amersham Pharmacia Biotech,
Freiburg, Germany) after tissue dissociation. PBLs were
prepared by slow-speed centrifugation as previously de-
scribed (54). Cells were maintained in RPMI 1640 medium
with Glutamax (GIBCO, UK) supplemented with 10% FCS at
40C in a CO2 (5%) incubator.
Chemical bursectomy
To deplete B cells from bursal follicles, chicks were injected
intramuscularly with 300 ll of a 1% solution of cyclophos-
phamide in 0.9% NaCl on days 1, 2, 3 and 4 after hatch.
On day 10, the treated animals were killed and tissue sam-
ples were collected for RNA preparation and histology.
RNA isolation and northern blot analysis
RNA was derived from various organs and from isolated
cells using TRIZOLTM reagent (GIBCO, Karlsruhe, Germany)
according to the manufacturer’s protocol. The indicated
amounts of RNA were size fractionated by electrophoresis
through an agarose gel containing 4% formaldehyde using
standard procedures before transfer onto a nylon mem-
brane. For hybridization, cDNAs containing the complete
ORFs of chBAFF (28) and chicken GAPDH (chGAPDH) (55)
were digested with PstI/EcoRI and NotI/XhoI, respectively.
[32P]-radiolabeled cDNA probes were generated using the
High Prime DNA labeling kit (Roche Diagnostics, Mannheim,
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Germany) and hybridization was performed with QuickHyb
Hybridization Solution (Stratagene, Heidelberg, Germany).
In situ hybridization
chBAFF-specific PCR products coding for the extracellular
part of chBAFF were cloned between the EcoRI and HindIII
restriction sites of vector pGEM-4Z (Promega, Mannheim,
Germany). Purified plasmids were digested with EcoRI and
HindIII for sense and antisense riboprobes, respectively.
Radiolabeled RNA probes were prepared from the resulting
linearized plasmids using T7 and SP6 polymerases (Strata-
gene) and a[33P]UTP. Cryostat sections from bursal tissue of
10 lm thickness were fixed for 5 min in 4% buffered formal-
dehyde, washed twice in PBS, treated for 7 min at room
temperature (RT) with 24 U ml1 of Pronase K in TE buffer
(Roche Diagnostics), washed again twice with PBS and in-
cubated for 10 min in 0.25% acetic acid anhydride solution.
After further washes in PBS, sections were postfixed in 4%
buffered formaldehyde (5 min, RT), washed again, dehy-
drated in an ascending alcohol series and air-dried. After
addition of 75 ll hybridization solution [250 ng ml1 probe,
50% formamide, 20% dextran sulfate, 10 mM EDTA, 1 mg
ml1 of yeast tRNA (Invitrogen, Karlsruhe, Germany), 10 mM
dithiothreitol (Applichem, Darmstadt, Germany), 200 mM
NaCl, 10 mM Tris–HCl pH 7.5, 5 mM EDTA, 5 mM NaH2PO4,
5 mM Na2HPO4, 0.1% w/v SDS, 0.1% w/v Ficoll 400, 0.1%
w/v polyvinylpyrrolidone, 20 units ml1 of heparin], sections
were sealed with Hybri-well press seal-hybridization cham-
bers (Sigma, Taufkirchen, Germany) and incubated in a hu-
midified chamber overnight at 55C. Unbound probes were
removed by two washes in 23 saline–sodium citrate (SSC),
followed by a 30-min RNAseA digestion (20 lg ml1 in 0.5 M
NaCl/10 mM Tris/1 mM EDTA) at 37C and further two
washes in 23 SSC, 13 SSC, 0.53 SSC for 5 min each and
a high stringent wash in 0.13 SSC for 30 min at 60C. After
a dehydrating step in an ascending alcohol series, slides
were air-dried and processed for autoradiography with NTB-
2 Emulsion, D-19 Developer and Fixer (Kodak, Stuttgart,
Germany). Finally, sections were counterstained with Mayer’s
Hematoxylin (Sigma), dehydrated one more time and mounted
in Eukitt mounting medium (Fluka, Buchs, Switzerland).
Histology
Bursal tissue was embedded in Tissue-Tek (Sakura Finetek,
Heppenheim, Germany), snap frozen in liquid nitrogen and
stored at 80C. Cryostat sections (7 lm thick) were
mounted on Super FrostPlus slides (Nunc, Wiesbaden,
Germany), air-dried and fixed in cold acetone for 10 min.
For immunohistochemical staining, sections were rehydrated
in PBS and blocked for 20 min with 10% normal horse serum
in PBS. This was followed by an overnight incubation with
the anti-chicken Bu1 antibody AV20 (0.5 lg ml1 in PBS-T/
SBA, Birmingham, AL, USA) at 4C and incubations with bio-
tinylated horse anti-mouse Ig (7.5 lg ml1 in PBS/1% BSA,
Vector Laboratories, Burlingame, CA, USA) for 30 min at
RT and StreptABComplec/HRP (DakoCytomation GmbH,
Hamburg, Germany) according to the manufacturers’ proto-
col. Peroxidase activity was developed using 3,3#diamino-
benzidine-tetrahydrochloride (Sigma). Subsequently, sec-
tions were counterstained with Mayer’s Hematoxylin (Sigma),
gradually dehydrated with graded alcohol and mounted in
Eukitt mounting medium (Fluka).
To visualize successful B cell depletion in cyclophosphamide-
treated birds, cryostat sections were prepared as described
above and subjected to a standard hematoxylin and eosin
staining.
Polyclonal antiserum
To generate a polyclonal antiserum against chBAFF, a rabbit
was immunized with affinity-purified recombinant His-tagged
chBAFF, expressed in Escherichia coli (28). The IgG fraction
of the serum was purified by affinity chromatography on
a Protein A–Sepharose column (Amersham Pharmacia Bio-
tech) and used for western blotting.
Cell lysis and western blotting
For cell lysis, organs were minced through a steel sieve imme-
diately after extraction. The resulting cell suspension was
sedimented on ice for 10 min whereupon the supernatant was
centrifuged. The cell pellet was re-suspended in cold PBS
with Ca++ and Mg++ (DPBS). Cells were counted and washed
again in DPBS. All cells were lysed for 45 min on ice in lysis
buffer (1 ml per 5 3 107 cells) [150 mM NaCl, 50 mM Tris–Cl
pH 7.4, 1 mM EDTA, 1% Triton X-100 and a protease inhibi-
tor mixture (complete, Roche Diagnostics)]. The nuclear and
insoluble components were removed by a 16 000 3 g cen-
trifugation step for 30 min at 4C and the supernatant was
used for western blotting. Purified Flag–chBAFF or cell
lysates were diluted in 23 Laemmli buffer and separated on
12% SDS-PAGEs under reducing conditions. Proteins were
transferred to nitrocellulose by semidry blotting as described
(56). Membranes were blocked with 4% skim milk and
incubated with HRP-conjugated mouse anti-Flag M2 (Sigma)
or 5 lg ml1 of rabbit anti-chBAFF followed by HRP-coupled
goat anti-rabbit IgG (Jackson, Cambridgeshire, UK). Mem-
branes were developed with the ECL western blotting detec-
tion reagent (GE Healthcare, Buckinghamshire, UK).
In vitro survival assay
Cells were cultured in standard RPMI 1640 medium supple-
mented with Glutamax and 10% FCS at 5 3 106 cells per
well in 24-well plates at 40C. Supernatants of 293 cells
stably transfected with either the Flag–chBAFF expression
construct or with an empty vector (28) were added to the
culture medium at a final concentration of 5%. The fre-
quency of living B cells [light chain (L chain)+/propidium
iodide (PI)] was analyzed by flow cytometry as described
below. Absolute numbers of viable cells were determined by
trypan blue exclusion and absolute numbers of viable
B cells were calculated from these data.
Splenic and bursal B cell preparations of >95 and 99%
purity, respectively, were obtained by magnetic cell sorting
on MACS separation columns LS (Miltenyi Biotec GmbH,
Germany) using a chicken Ig L chain-specific antibody
(Southern Biotechnology Associates, Birmingham, AL, USA),
anti-mouse Ig–FITC (Sigma) and anti-FITC microbeads
(Miltenyi Biotec GmbH).
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To obtain B cell-free preparations from splenic leukocytes
(<1.5% L chain+ cells), cells were stained alike and deple-
tion was done using MACS separation columns LD (Miltenyi
Biotec GmbH).
Cell proliferation
For cell proliferation assays, 5 3 105 bursal or splenic lympho-
cytes per well were cultured in 96-well plates in the presence
or absence of 5% chBAFF-containing 293 supernatant. Poly-
clonal stimulation was achieved by the addition of 10 ng ml1
phorbol myristate acetate (PMA) (Sigma). After 24 h, cells
were pulsed with [3H]thymidine ([3H]TdR) and harvested
16 h later.
Flow cytometry
Staining of the cells for flow cytometric analysis was per-
formed according to standard procedures. Cells were
stained with mAbs against IgM (M1) (57), L chain (Southern
Biotechnology Associates), Bu1(58) or a mixture of anti-
TCRyd (TCR1), TCRa/vb1 (TCR2) and TCRa/vb2 (TCR3) (59)
followed by an anti-mouse Ig–FITC conjugate (Sigma).
Receptor binding of chBAFF was shown as described re-
cently (28). Briefly, after staining with mAb AV20 and an
anti-mouse–FITC conjugate, cells were incubated with Flag-
chBAFF-containing 293 supernatants and normal mouse se-
rum, followed by staining with biotinylated anti-Flag mAb
(M2) (Sigma) and streptavidin–PE (Southern Biotechnology
Associates).
To demonstrate the ability of the soluble human B cell mat-
uration antigen (hBCMA)-Fc construct to block the interac-
tion of chBAFF with its receptor, different concentrations of
hBCMA-Fc were pre-incubated with chBAFF-containing super-
natants for 20 min at RT. Subsequently, these preparations
were used to stain chBAFFR-positive cells as described
above.
Dead cell discrimination for in vitro survival assays was
done through staining with PI (2.5 lg ml1). Analysis was
performed with a FACScan flow cytometer (Becton Dickin-
son, Heidelberg, Germany) using Cell Quest Plus software.
In ovo and post-hatch neutralization of chBAFF
hBCMA-Fc consisting of the signal peptide of IgG1 heavy
chain, amino acid residues 2–54 of hBCMA and the Fc
domain of human IgG1 was expressed in 293 cells and sub-
mitted to Protein A affinity purification (60). For in ovo neu-
tralization of chBAFF activity, fertilized eggs were injected
with 100 lg of hBCMA-Fc (1 mg ml1 in PBS) intravenously
(i.v.) on day 15 of embryogenesis as described (61). On
day 18, embryos were extracted and organs were subjected
to immunohistochemistry.
To block chBAFF activity after hatch, 1-day-old chicks were
given intra-peritonial (i.p.) injections of 300 lg of hBCMA-Fc.
For one experimental approach, this treatment was repeated
on days 5 and 8. On day 10, spleens, cecal tonsils and bur-
sae were removed and the spleen/body weight index and the
bursa/body weight index were calculated. For a second set
of experiments, 1-day-old chicks were injected once a day
over a period of 5 days and analyzed on day 6. Lymphocytes
from spleens and cecal tonsils were separated on Ficoll
(Amersham Pharmacia Biotech) and subjected to analysis by
flow cytometry. In order to obtain sufficient numbers of cecal
tonsil lymphocytes, organs from all birds in each group were
pooled prior to lymphocyte isolation.
Results
BAFF is expressed early during B cell ontogeny
In our earlier work we have shown that chBAFF is mainly
expressed in the bursa of Fabricius and that BAFFRs are
found on all B cells including bursal B lymphocytes. To fol-
low up on this initial finding, BAFF expression was investi-
gated by northern blot analysis of tissue samples from
spleen, bursa, liver and thymus using a radiolabeled PCR
fragment derived from the BAFF sequence. Tissue samples
were obtained from day 10, 14 and 18 embryos and birds
at the age of 1 day (Fig. 1A). No cytokine expression was
found in tissues from day 10 embryos. On embryonic day
(ED) 14, weak BAFF expression could be detected in the
bursa but not in the spleen and liver tissue. A strong up-
regulation of BAFF gene expression was observed in the
bursa between EDs 14 and 18 which further increased until
hatch (D1). In the spleen, clearly detectable BAFF signals
were not found until D1. No BAFF expression was observed
in the thymus at any time point. After hatch, a similar expres-
sion pattern was found with a strong BAFF signal in the
bursa, a weak signal in the spleen and no expression in the
thymus (data not shown).
To obtain evidence for expression of the BAFF protein in the
bursa, we developed a BAFF-specific polyclonal antiserum
by repeated immunization of a rabbit with purified E. coli-
derived protein. Binding specificity was confirmed by west-
ern blot analysis. The chBAFF antiserum recognized purified
Flag-tagged chBAFF with a similar reactivity pattern as the
Flag-epitope-specific M2 mAb (Fig. 1B). Next, cell lysates
derived from bursa, spleen and thymus were subjected to
SDS-PAGE, transferred to nitrocellulose and probed with the
chBAFF antiserum. As expected from the gene expression
studies, BAFF protein was readily detectable in bursal
lysates and, with a much weaker signal, in spleen samples
but not in thymic control lysates (Fig. 1C). Collectively, these
experiments demonstrated that BAFF is expressed as a ma-
ture protein in the bursa of Fabricius and in the spleen.
BAFF is primarily expressed by B lymphocytes
To characterize the cell types expressing BAFF in the
chicken, we next performed in situ hybridization studies on
bursal tissue sections. Cytokine expression was found
throughout bursal follicles and to some extent in the inter-
follicular connective tissue (Fig. 2). While staining was seen
in both cortex and medulla of bursal follicles, the stronger
signal was seen in the medulla. These results indicated that,
in contrast to mammals, chickens may express BAFF primar-
ily in B lymphocytes. To further address this hypothesis, we
used the chemical bursectomy technique with cyclophos-
phamide to selectively deplete B cells from the bursa, leaving
the bursal stroma intact. Successful bursectomy was achieved
in all birds as revealed by histology, demonstrating the loss
of organized follicular structures after cyclophosphamide
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treatment (Fig. 3A). Northern blot analysis of individual bur-
sal and splenic tissue samples showed strong BAFF expres-
sion in bursa samples and clear but significantly weaker
expression in spleens of untreated birds. No cytokine mRNA
could be demonstrated in the tissues of B cell-depleted ani-
mals (Fig. 3B). As demonstrated by chGAPDH hybridization,
the comparison of total organ samples results in unequal
RNA loading of the gels. However, an analysis performed
with comparable amounts of total RNA (Fig. 3C) yielded the
same conclusion that no BAFF mRNA could be detected in
B cell-depleted animals while an intense signal was found in
control animals.
Expression analysis was next performed on isolated cell
populations. B cells were purified from bursa and spleen
samples by positive sorting with magnetic beads. In addi-
tion, splenic lymphocyte preparations were depleted from
B cells by the same technique (<1% B cells). chBAFF expres-
sion in these preparations was again determined by northern
blot analysis (Fig. 4). As expected, a signal was found in the
bursal control sample and an even stronger signal was
found in RNA prepared from positively sorted bursal B cells.
Furthermore, chBAFF mRNA was found in total spleen sam-
ples and splenic leukocyte preparations. Importantly, a clear
cytokine expression signal could be detected in purified
splenic B cells, while B cell-depleted preparations gave no
signal. These data strongly indicate that BAFF is primarily
expressed by B lymphocytes and to a much lesser degree,
if at all, by the stromal tissue of the bursa and the spleen.
BAFFR is expressed early in B cell development
Since eukaryotic recombinant chBAFF shows avid binding to
B cells, we next analyzed expression of BAFFRs on B lympho-
cytes from different developmental stages (Fig. 5). Pre-
bursal, bursal and post-bursal B lymphocytes were identified
by their expression of the B cell-specific antigen Bu1 with
Fig. 1. Early chBAFF expression during B cell ontology. (A) RNA from
spleen (S), bursa (B), liver (L) and thymus (T) was isolated at the
indicated time points of embryonic development (EDs 10–18) and
from 1-day-old chicks (D1), respectively. chBAFF cDNA (28) was
used to probe a northern blot containing 10 lg of RNA per lane (a).
Reprobing of the membrane was performed with chGAPDH cDNA
(55) to compare the relative amounts of RNA per lane (b). The gel
positions of the 28S rRNA and 18S rRNA are indicated. (B) A total of
1 lg of Flag–chBAFF per lane was subjected to SDS-PAGE under
reducing conditions and probed by western blotting with either Flag-
specific mAb M2 (lane 1) or chBAFF antiserum (lane 2). The
prominent bands at 18 and 23 kDa represent the Flag-tagged
protein. Minor reactivity with anti-Flag at 36 kDa most likely represents
Flag–BAFF aggregates. The reactivity found with the anti-chBAFF
serum at 72 kDa can be attributed to an unspecific reactivity of the
antiserum. (C) The chBAFF antiserum was used to analyze cell
lysates from bursa (lane 2), spleen (lane 3) and thymus (lane 4) by
western blotting. Recombinant Flag–chBAFF served as positive
control (lane 1).
Fig. 2. In situ hybridization shows chBAFF expression in bursa
follicles. Bursa cryostat sections from 6-week-old birds were
hybridized with [33P]-labeled antisense (A) and sense probes
(B) for chBAFF and counterstained with hematoxylin. The asterisk
indicates the follicle medulla; the arrow marks the follicle cortex; 40-
fold magnification.
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the mAb AV20. AV20+ pre-bursal stem cells were detectable
in ED 10 spleens but did not show BAFFR expression. The
frequency of pre-bursal B cells increased during the next 4
days of embryogenesis and these cells became weakly pos-
itive for BAFFR. At the same time, B cells became detect-
able in the early bursal anlage and showed a comparable
BAFFR expression level to the splenic pre-bursal cell popu-
lation. BAFFR expression significantly increased during the
following days until hatch. At ED 18 and later time points, all
AV20+ cells in the bursa were positive for BAFFR and after
hatch AV20+ cells in the spleen showed the same intensity
of BAFFR expression.
chBAFF regulates peripheral B cell homeostasis
Previously, we have shown by in vitro studies that chBAFF is
a potent survival factor for splenic B lymphocytes. To investi-
gate if this functional property applies to peripheral B cells,
in general, we isolated lymphocytes from spleens and cecal
tonsils, one of the few organized secondary lymphoid struc-
tures in the chicken, and cultured these cells in the pres-
ence or absence of chBAFF. Cytokine treatment led to
a significant increase in viable B lymphocyte numbers in
spleen cell cultures as expected from our earlier work
(Fig. 6A). This effect was even more pronounced in cultures
of cecal tonsil lymphocytes and B cells purified from spleens
by magnetic cell sorting (>95% B cells). The survival factor
activity was also observed when cell proliferation of splenic
B lymphocytes was induced by PMA. A comparison of prolif-
erative activities in chBAFF-treated and control cultures (Fig.
6B) after 40 h of incubation showed a significant increase of
[3H]TdR uptake in cultures with the cytokine from an average
of 754 counts per minute (c.p.m.) (medium) and 33.643
c.p.m. (PMA) up to 2348 c.p.m. (BAFF) and 64.737 c.p.m.
(PMA + BAFF). These data confirm our previous observa-
tions and support the concept that BAFF is an important reg-
ulator of B cell homeostasis in secondary lymphoid organs in
general.
To investigate the functional relevance of chBAFF in vivo,
we made use of our earlier observation that this avian
Fig. 3. Chemical bursectomy abrogates chBAFF expression. B cell depletion in young chicks was achieved by the chemical bursectomy method
using cyclophosphamide. (A) To control successful bursectomy, hematoxylin and eosin staining from cryostat sections of bursa from all treated
(Bx) and control birds was performed. A representative data set is shown where clearly developed B cell follicles in the control and remnants of
follicular connective tissue in bursectomized birds are marked with a dashed line. (B) RNA samples from bursa and spleens of four control
(C1–C4) and four bursectomized (Bx1–Bx4) birds representing a total organ equivalent were subjected to northern blot analysis using
a chBAFF-specific cDNA probe (a). Bars indicate the gel positions of the 28S and 18S rRNA. A chGAPDH-specific cDNA probe was used to
estimate the relative amounts of loaded RNA (b). (C) Likewise, northern blotting with 10 lg of bursa RNA per lane from control (C1–C3) and
bursectomized (Bx1–Bx2) birds was performed using probes for chBAFF (a) and chGAPDH (b).
Fig. 4. chBAFF is expressed by B cells. (a) Expression analysis was
done by northern blotting with a chBAFF-specific cDNA probe using
10 lg of RNA each from entire organs or isolated cell populations:
complete bursa (1), purified bursal B cells (>99.5% purity) (2),
complete spleen (3), splenic leukocytes obtained by density
centrifugation (4), purified splenic B cells (>96% purity) (5), B cell-
depleted splenic leukocytes (<1.5% B cells) (6). The gel positions of
the 28S and 18S rRNA are marked by black bars. (b) The RNA
integrity and equal loading was controlled by hybridization with
a chGAPDH-specific probe.
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cytokine strongly binds to hBCMA in a receptor–ligand inter-
action ELISA (28). To further demonstrate that BCMA can
block the binding of chBAFF to its receptor on chicken cells,
we pre-incubated chBAFF with increasing concentrations of
hBCMA-Fc prior to the staining of the BAFFR on B cells. Ad-
dition of 2.5 lg ml1 of hBCMA-Fc completely blocked
chBAFF interaction with its receptor (Fig. 7A). We therefore
used hBCMA-Fc as a soluble decoy receptor to neutralize
the biological activity of chBAFF in young chicks. Five 1-
day-old birds per group received either hBCMA-Fc in PBS
at a dose of 300 lg per animal i.p. and additional treatments
3 and 6 days later or PBS alone. The birds were killed on
day 10 after hatch. hBCMA treatment did not affect animal
health and body weights. However, spleen weights were re-
duced from an average of 110 mg in the controls to 66 mg
in hBCMA-Fc-treated birds (Table 1).
Spleens and cecal tonsils were analyzed for the relative
numbers of B cells and T cells by flow cytometry. hBCMA-
Fc treatment significantly reduced the frequency of B cells
in the spleens and in the cecal tonsils in comparison with
mock-treated birds (Fig. 7B and C). As a consequence, the
relative numbers of T cells increased in hBCMA-Fc-treated
animals in both tissues. The reduced number of splenic
B cells in the absence of functional BAFF in young chickens
clearly demonstrates the important role of BAFF in the homeo-
stasis of mature B cells.
chBAFF promotes survival of immature bursal B cells
The analysis of BAFF and BAFFR expression revealed the
existence of both the cytokine and its receptor at very early
stages of chicken B cell development. This observation sug-
gested a new role for chBAFF during maturation of bursal
B cells. To further address this hypothesis, chBAFF was added
to cultures of bursal lymphocytes. Although the addition of
chBAFF could not abrogate the gradual loss of viable cells,
it induced a significant delay of bursal B cell death (Fig. 8A).
The bursa of Fabricius is a highly proliferating tissue and
pulsing of unstimulated bursal lymphocytes with [3H]TdR im-
mediately after cell isolation yielded incorporation values be-
tween 20 000 and 40 000 c.p.m. However, this proliferating
activity decreased rapidly with time of culture (data not
shown). The presence of BAFF in these cultures caused
a markedly higher proliferation rate after 40 h (Fig. 8B).
To verify these effects on immature B cells in vivo, we
again took advantage of the neutralizing ability of hBCMA.
In the initial experiment with i.p. application of 300 lg of
Fig. 5. chBAFFR is expressed early during embryogenesis. Leukocytes from spleen (upper panel) and bursa (lower panel) were isolated at
different times of embryogenesis (EDs 10–18) and on the day of hatch (D1). Binding of Flag–chBAFF to AV20+B cells was analyzed by flow
cytometry.
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Fig. 6. chBAFF promotes the survival of peripheral B cells in vitro.
(A) Leukocytes from cecal tonsils (CT) and spleen, as well as purified
splenic B cells, were cultured in the presence or absence of 5%
conditioned medium containing Flag–chBAFF. After 48 h, the absolute
number of viable B cells was determined by a combination of trypan
blue exclusion (absolute number of viable cells) and FACS anal-
ysis (frequency of viable B cells). (B) A total of 1 3105 splenocytes
per well were cultured with or without 5% of Flag-chBAFF-containing
medium in the presence or absence of 10 ng ml1 of PMA. After 24 h,
cells were pulsed with [3H]TdR and harvested 16 h later. Data
represent mean 6 SD of three independent experiments (*P< 0.05,
**P< 0.01, t-test).
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hBCMA as described above, a trend toward a reduction in
bursal weights from a mean of 323–249 mg was observed
(Table 1), although this decrease was not statistically signifi-
cant. In order to neutralize chBAFF activity at a very early
stage of B cell development, we used the i.v. injection route
in ovo with 100 lg of hBCMA per egg on day 15 of embryo-
genesis. When bursae of hBCMA-Fc-treated and control
animals were taken from day 18 embryos, immunohisto-
chemical staining with the B cell marker AV20 revealed an
obvious decrease in the number of B cell follicles due to
BAFF neutralization (Fig. 9A). To quantify this effect, the
number and area of AV20-positive B cell follicles were deter-
mined. hBCMA treatment in ovo reduced the number of
B cell follicles from an average of 129 in control bursae
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Fig. 7. Neutralization of chBAFF in vivo decreases peripheral B cell frequencies. (A) Medium containing Flag–chBAFF was incubated with the
indicated concentrations of hBCMA-Fc and subsequently used to analyze binding to chBAFFRs on bursal B cells by flow cytometry. Staining with
control supernatant and Flag–chBAFF without hBCMA served as controls. (B and C) Beginning on the day of hatch, four chicks per group
received i.p. injections with 300 lg of hBCMA-Fc per animal or PBS once each day over a period of 5 days. On day 6, spleens and cecal tonsils
were analyzed by flow cytometry. (B) Splenocytes from control (upper panel) and hBCMA-treated birds (lower panel) were stained against
surface IgM. Two representative FACS profiles per group are shown. (C) B and Tcell frequencies in spleens and cecal tonsils were determined by
staining with antibodies against Bu1 (AV20) and the TCR (using a combination of TCR1, TCR2 and TCR3). Data represent means 6 SD (n ¼ 4).
Cecal tonsils from each group were pooled prior to lymphocyte isolation (*P< 0.05, **P< 0.01, t-test).
Table 1. Influence of chBAFF neutralization on spleen and bursa weight
Body
weight (g)
Spleen
weight (mg)
Bursa
weight (mg)
Spleen/body
weight index (mg g1)
Bursa/body
weight index (mg g1)
hBCMA 65.6 6 7.1 66.0 6 55.7 249.3 6 138.4 1.18 6 1.5 6.9 6 3.9
Control 70.7 6 1.9 110.0 6 87.8 323.0 6 158.0 3.0 6 2.5 8.6 6 4.5
Five animals per group were injected with either 300 lg hBCMA-Fc or PBS i.v. on days 2, 5 and 8. On day 10, spleen and body weights were
determined, and the spleen/body weight index of each animal was calculated. Mean values 6 SDs are given for each group.
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to 63. Likewise, the mean follicle area in hBCMA-treated
bursae was significantly smaller than that in untreated con-
trols (40 versus 65 mm2) (Fig. 9B).
Discussion
The immune system of most domestic animals differs from
that of the common immunological model organism, the
mouse, in a variety of aspects. This is particularly true for
birds which use a unique organ, the bursa of Fabricius, for
B cell differentiation (18, 62, 63). The availability of EST data-
bases and the recent publication of the chicken genome se-
quence (64, 65) have finally provided the information
required to investigate the phylogeny, structure and function
of the avian immune system (65). Sequence information from
the animal genome projects have now to be translated into
functional data to allow studies on the host response to
pathogens and to understand the evolutional differences
among higher vertebrates. Here we further characterize the
biological properties of the recently discovered avian homo-
logue of BAFF and show that this cytokine has conserved
functions in vitro and in vivo, as well as unique properties
which have not been described in mammals thus far.
Although mammalian BAFF is part of a complex system con-
taining the two ligands BAFF and APRIL and the three re-
ceptors BAFFR, TACI and BCMA, the situation in birds seems
to be simpler in this respect. Indeed, so far no homologues
of APRIL, BCMA and TACI can be detected in the chicken
genome (51), leaving birds with a single ligand–receptor
pair consisting of chBAFF and chBAFFR, the homologue of
the mammalian BAFFR/BR3.
Previous northern blot analysis had shown that chBAFF is
expressed in the spleen of mature birds (28, 38), as ex-
pected from data obtained in mice (50, 66). Surprisingly, the
highest expression levels were found in the bursa of Fabri-
cius, the bone marrow equivalent of birds. This observation
contrasts with findings in mice and humans where BAFF is
essentially absent from the bone marrow and is not required
for early B cell differentiation (47, 50). To further address this
discrepancy, we performed ontogenic studies which showed
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Fig. 8. chBAFF decelerates death of bursal lymphocytes in culture.
(A) Bursal lymphocytes were cultured in the presence or absence of
5% chBAFF-containing medium. At the indicated times, the number of
viable B cells in these preparations was determined by combining
trypan blue exclusion and FACS analysis. (B) A total of 1 3105 bursal
lymphocytes per well were cultured with or without 5% Flag-chBAFF-
containing medium. After 24 h, cells were pulsed with [3H]TdR and
harvested 16 h later. Data represent mean 6 SD of three independent
experiments (**P < 0.01; t-test).
Fig. 9. In ovo neutralization of chBAFF interferes with embryonic
B cell development. (A) On day 15 of embryogenesis, fertilized eggs
were i.v. injected with 100 lg of hBCMA-Fc (at 1 mg ml1 in PBS). On
day 18, embryos were extracted and bursae were subjected to
immunohistochemical staining for the B cell marker Bu1 followed by
counterstaining with hematoxylin. Bursae of Fabricius from four
treated and four untreated animals are shown. (B) Number of follicles
(left) and mean follicle area (right) from the sections shown in (A) was
determined using the AXIO-Vision Rel.4.5. software (Zeiss). Data
represent mean 6 SD (*P< 0.05, **P < 0.01, t-test).
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that chBAFF is first expressed in the bursa when pre-bursal
stem cells home into this organ around EDs 10–14 (11). As
the number of bursal B cells expands, chBAFF expression
is strongly up-regulated. Importantly, no cytokine expression
is observed in peripheral lymphoid organs prior to B cell em-
igration form the bursa which starts around the day of hatch
(17). mRNA expression correlates well with the expression
of the chBAFF protein, which was detectable in bursa and,
at lower levels, in spleen lysates. The simultaneous appear-
ance of chBAFF and B cells in the bursa and spleen is
an indication that chBAFF might be primarily expressed
by B cells.
This hypothesis was confirmed by in situ hybridization
studies on bursal tissue sections. In agreement with a previ-
ous report (52), staining was observed throughout the bursal
follicles with a slightly higher expression level in the medulla,
arguing against a restricted expression by dendritic or other
myeloid cells, which is characteristic for mice and humans
(37, 67). Selective depletion of proliferating lymphocytes in
the bursa using cyclophosphamide (68) also showed that
the elimination of B cells was associated with the loss of
chBAFF mRNA expression. Interestingly, an identical result
was obtained for chBAFF expression in the spleen. Finally,
chBAFF message was found in control tissue samples and
highly enriched B cell preparations from bursa and spleen
but was completely absent in spleen cell preparations de-
pleted from B cells. Collectively, these studies provide
strong evidence that B cells are the main source of chBAFF,
which is in striking contrast with humans and mice, where
BAFF expression by B cells is only seen in malignant cells
(36, 43, 44, 67). Since the BAFF system has not been inves-
tigated in other domestic mammals, it is unclear whether
BAFF expression by B cells is unique to birds or may also
be found in other species in which B cells develop in the
GALT.
The presence of high levels of chBAFF mRNA and protein
in the bursa suggests a unique role for this cytokine in B cell
development in birds. This is supported by chBAFFR ex-
pression in immature chicken B cells, which can be detected
by indirect fluorescence staining with the soluble recombin-
ant Flag–BAFF protein and flow cytometric analysis (28).
Pre-bursal B cells in ED 10 spleens do not bind BAFF, but
as these cells colonize the bursal anlage (EDs 10–14),
BAFFR is weakly expressed on peripheral B cell progenitors
and on early bursal B cells. BAFFR expression level on bur-
sal lymphocytes further increases with bursal maturation,
while the few remaining pre-bursal stem cells in the spleen
remain BAFFR negative. The next wave of BAFFR-expressing
B cells in peripheral lymphoid tissues is observed when ma-
ture B cells start to emigrate from the bursa to peripheral
secondary lymphoid tissues.
In mice, BAFF acts as a central mediator in the homeosta-
sis of mature B cell subsets (34, 40), mainly through the
modulation of cell survival (66, 69–72). This function seems
to be evolutionary conserved, since the addition of recombi-
nant chBAFF to cultures from different secondary lymphoid
organs significantly delays the otherwise rapid cell death.
The effect of chBAFF on B cell survival is more pronounced
on purified B cells, indicating that chBAFF acts directly on
mature B cells and not through the activation of other cells
in the mixed cultures. Stimulation with chBAFF does not di-
rectly induce B cell proliferation (28) but seems to delay ap-
optotic cell death of unstimulated B cells. This cytokine
activity is more clearly seen after polyclonal expansion of
splenic B cells with PMA stimulation, in which setting BAFF
most likely rescues cells from activation-induced cell death (73).
Further elucidation of BAFF function in the chicken was
approached through in vivo neutralization of cytokine activity.
hBCMA-Fc was used for this purpose, as chBAFF cross-
reacts with the mammalian receptors TACI, BCMA and
BAFFR (28) and as hBCMA-Fc was able to prevent binding
of chBAFF to B cells in a dose-dependent manner. Attempts
to inactivate endogenous chBAFF in vivo by repeated injec-
tions of the soluble decoy receptor decreases the spleen/
body weight index, though high variability prevents a statisti-
cally significant conclusion. This variability is probably due,
at least in part, to the fact that in the chicken system outbred
animals have to be used. Importantly, inactivation of endog-
enous chBAFF led to a significant reduction of relative B cell
numbers in the peripheral lymphoid organs of all treated ani-
mals. Though either an absolute increase in T cells or an ab-
solute decrease in B cells could explain the alteration in the
B/T cell ratio, the latter corresponds much better with the de-
creased spleen/body weight index and the known function
of BAFF in mammals, where BAFF activity was inhibited ei-
ther with a decoy receptor (74) or through BAFFR gene
knockout (34, 75). We conclude that the function of BAFF in
the homeostatic control of the mature B cell compartment is
conserved in birds and mammals. However, homeostatic
control of the peripheral B cell pool in birds must differ from
that of mammals in certain details, as birds display a lifelong
requirement for B cell maintenance in the periphery as a con-
sequence of bursa involution (19). Unfortunately, the lack of
suitable markers for the differentiation of mature B cells sub-
sets in chickens hinders a more detailed analysis of the tar-
get populations responsive to BAFF. As BAFF binding was
found on all B cells isolated from the spleen or cecal tonsils
(28), it is, however, likely that BAFF is required for all mature
chicken B cells.
Our observation that purified immature bursal B cells also
express BAFFR and respond to BAFF in vitro by enhanced
survival and thymidine incorporation strongly indicates an
additional role for chBAFF in early B cell development. The
bursa to body weight index decreases in birds with severe
depletion of peripheral B cells. Although this index was
slightly decreased in birds treated with BCMA Ig, the differ-
ence was not significant and histological examination of the
bursal tissue did not reveal obvious morphological differen-
ces between treated and untreated groups, suggesting ei-
ther that BAFF is not essential for immature B cells or that
the treatment protocol might have been insufficient to neu-
tralize the high amounts of BAFF in the bursa. We favor the
second hypothesis, because administration of BCMA-Fc
in ovo at ED 15, when B cell expansion in the bursa has just
begun, efficiently reduced the number of B cell follicles in
comparison to sham-treated embryos. A major regulating
mechanism for developmental processes in the bursa is ap-
optosis (76) and it has been shown that both pro- and anti-
apoptotic Bcl-2 family members like Bax, Bcl-2 and Nr13
play a role in this process (77, 78). Since BAFF-induced
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B cell survival in humans and mice is mainly mediated by
the up-regulation of anti-apoptotic and down-regulation of
pro-apoptotic Bcl-2 family members (48, 71), chBAFF might
also interfere with these pathways to regulate the balance
between cell death and survival in immature chicken B cells.
Taken together, these data indicate an important function of
chBAFF in bursal B cell development. The dependence of
immature B cells for BAFF-mediated signals in a primary
lymphoid organ is so far unique to chicken. Indeed, B cell
development in the bone marrow of mice proceeds effi-
ciently in the absence of BAFF (47, 50).
Based on these results, we conclude that BAFF has main-
tained its function in the homeostatic control of the mature
B cell compartment since the divergence of mammals and
birds some 350 million years ago (79). Our unexpected ob-
servation that BAFF is also involved in early B cell develop-
ment in birds fits two models. In the first one, the evolution
of the bursa (the avian B cell differentiation organ) is linked
to the gain of a new function for BAFF. Until recently, it
was believed that B cell development in a gut-associated
lymphoid organ was unique to birds (80). However, with the
demonstration that domestic mammals such as sheep and
rabbits rely on B cell development in the GALT, this concept
was revised (2). Therefore, a second model may be pro-
posed in which BAFF is an important cytokine for species
experiencing B cell development in the GALT, but that
the BAFF dependence of immature B cells may have been
lost during switch of B cell development from the GALT
to the bone marrow. Comparative studies on the BAFF
system in additional species should help to clarify these
hypotheses.
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Abbreviations
APRIL a proliferation-inducing ligand
BAFF B cell-activating factor of the tumor necrosis factor
family
BCMA B cell maturation antigen
BCR B cell receptor
chBAFF chicken B cell-activating factor of the tumor necrosis
factor family
chGAPDH chicken GAPDH
c.p.m. counts per minute
DPBS PBS with Ca++ and Mg++
ED embryonic day
GALT gut-associated lymphoid tissue
hBCMA human B cell maturation antigen
[3H]TdR [3H]thymidine
i.p. intra-peritoneal
i.v. intravenous
L chain light chain
PI propidium iodide
PMA phorbol myristate acetate
RT room temperature
SSC saline–sodium citrate
TACI transmembrane activator, calcium modulator and CAML
interactor
TNF tumor necrosis factor
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